By expenditures
| Name | Title | Type |
|---|---|---|
| Richonda Pelzer | Chief Financial Officer | Auditee |
| Casey O'Donnell | President/CEO | Auditee |
| Jeffrey Weiss | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 369593 | 2024 | 2025-09-30 | Eisneramper LLP | $8.84M |
| 329334 | 2023 | 2024-11-21 | Zelenkofske Axelrod LLC | $9.35M |
| 42118 | 2022 | 2023-07-31 | Zelenkofske Axelrod LLC | $8.22M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 369593 | 2024 | 2025-09-30 | 1157314 | 2024-002 | Material Weakness | Yes | AB |
| 369593 | 2024 | 2025-09-30 | 1157313 | 2024-002 | Material Weakness | Yes | AB |
| 369593 | 2024 | 2025-09-30 | 1157312 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157311 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157310 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157309 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157308 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157307 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157306 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157305 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157304 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157303 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157302 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157301 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157300 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157299 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157298 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157297 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157296 | 2024-001 | Material Weakness | Yes | P |
| 369593 | 2024 | 2025-09-30 | 1157295 | 2024-001 | Material Weakness | Yes | P |
| 329334 | 2023 | 2024-11-21 | 1086120 | 2023-002 | Significant Deficiency | - | BM |
| 329334 | 2023 | 2024-11-21 | 1086119 | 2023-002 | Significant Deficiency | - | B |
| 329334 | 2023 | 2024-11-21 | 1086118 | 2023-002 | Significant Deficiency | - | B |
| 329334 | 2023 | 2024-11-21 | 1086117 | 2023-002 | Significant Deficiency | - | B |
| 329334 | 2023 | 2024-11-21 | 1086116 | 2023-001 | Significant Deficiency | - | L |
| 329334 | 2023 | 2024-11-21 | 1086115 | 2023-001 | Significant Deficiency | - | L |
| 329334 | 2023 | 2024-11-21 | 1086114 | 2023-001 | Significant Deficiency | Yes | L |
| 329334 | 2023 | 2024-11-21 | 1086113 | 2023-001 | Significant Deficiency | Yes | L |
| 329334 | 2023 | 2024-11-21 | 509678 | 2023-002 | Significant Deficiency | - | BM |
| 329334 | 2023 | 2024-11-21 | 509677 | 2023-002 | Significant Deficiency | - | B |
| 329334 | 2023 | 2024-11-21 | 509676 | 2023-002 | Significant Deficiency | - | B |
| 329334 | 2023 | 2024-11-21 | 509675 | 2023-002 | Significant Deficiency | - | B |
| 329334 | 2023 | 2024-11-21 | 509674 | 2023-001 | Significant Deficiency | - | L |
| 329334 | 2023 | 2024-11-21 | 509673 | 2023-001 | Significant Deficiency | - | L |
| 329334 | 2023 | 2024-11-21 | 509672 | 2023-001 | Significant Deficiency | Yes | L |
| 329334 | 2023 | 2024-11-21 | 509671 | 2023-001 | Significant Deficiency | Yes | L |
| 42118 | 2022 | 2023-07-31 | 626030 | 2022-001 | Significant Deficiency | - | P |
| 42118 | 2022 | 2023-07-31 | 49588 | 2022-001 | Significant Deficiency | - | P |